Abbott Laboratories (ABT)

NYSE: ABT · Real-Time Price · USD

131.06

0.31 (0.24%)

At close: May 01, 2025, 3:11 PM

Abbott Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	13.4B	5.72B	6.93B	7.07B	4.5B	3.69B	2.37B	477M	1.38B
Depreciation & Amortization	3.22B	3.24B	3.27B	3.54B	3.33B	3.01B	3.28B	3.02B	1.35B
Stock-Based Compensation	673M	644M	685M	640M	546M	519M	477M	406M	310M
Other Working Capital	-8.82B	-1.13B	-458M	-1.22B	-1.24B	-683M	-191M	1.26B	-586M
Other Non-Cash Items	482M	126M	215M	55M	425M	247M	32M	912M	1.43B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	293M	-1.16B	248M
Change in Working Capital	-9.22B	-2.48B	-1.52B	-771M	-892M	-1.33B	-148M	1.92B	-1.51B
Operating Cash Flow	8.56B	7.26B	9.58B	10.53B	7.9B	6.14B	6.3B	5.57B	3.2B
Capital Expenditures	-2.21B	-2.2B	-1.78B	-1.89B	-2.18B	-1.64B	-1.39B	-1.14B	-1.12B
Cash Acquisitions	1M	-837M	48M	-53M	16M	-122M	48M	-8.44B	-55M
Purchase of Investments	-169M	-159M	-185M	-173M	-83M	-103M	-131M	-210M	-2.82B
Sales Maturities Of Investments	28M	43M	152M	77M	10M	21M	73M	129M	3.71B
Other Investing Acitivies	9M	22M	22M	26M	19M	27M	48M	35M	42M
Investing Cash Flow	-2.34B	-3.13B	-1.74B	-2.01B	-2.21B	-1.81B	-1.36B	-9.62B	-248M
Debt Repayment	-537M	-2.48B	-699M	-248M	-50M	-1.6B	-8.45B	-1.91B	13.15B
Common Stock Repurchased	-1.29B	-1.23B	-3.79B	-2.3B	-403M	-718M	-238M	-827M	-522M
Dividend Paid	-3.84B	-3.56B	-3.31B	-3.2B	-2.56B	-2.27B	-1.97B	-1.85B	-1.54B
Other Financial Acitivies	264M	167M	n/a	255M	234M	298M	271M	-1.05B	53M
Financial Cash Flow	-5.4B	-7.09B	-7.64B	-5.49B	-2.78B	-4.29B	-10.39B	-5.28B	11.15B
Net Cash Flow	720M	-2.99B	83M	2.96B	2.98B	16M	-5.56B	-9.21B	13.62B
Free Cash Flow	6.35B	5.06B	7.8B	8.65B	5.72B	4.5B	4.91B	4.43B	2.08B